Description

Ligandrol is a novel nonsteroidal oral selective androgen receptor modulator currently being investigated in research as a potential treatment for conditions relating to muscle dystrophy and osteoporosis. Studies have shown that Ligandrol may have benefits in increasing muscle mass and preventing bone loss. More extensive research and randomized trials could potentially evaluate its efficacy in improving physical function and health outcomes in select populations.

LGD-4033
CAS Number	1165910-22-4
Molar Mass	338.253 g·mol−1
Chemical Formula	C14H12F6N2O
IUPAC Name	4-[(2R)-2-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-2-(trifluoromethyl)benzonitrile

MK677
CAS Number	159634-47-6
Molar Mass	528.67 g·mol−1
Chemical Formula	C14H12F6N2O
IUPAC Name	2-amino-2-methyl-N-[1-(1-methylsulfonylspiro[2H indole-3,4′-piperidine]-1′-yl)-1-oxo-3-phenylmethoxypropan-2-yl]propenamide